Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

被引：0
|
作者：
Nazzareno Galiè
Sean Gaine
Richard Channick
J. Gerry Coghlan
Marius M. Hoeper
Irene M. Lang
Vallerie V. McLaughlin
Cheryl Lassen
Lewis J. Rubin
Shu-Fang Hsu Schmitz
Olivier Sitbon
Victor F. Tapson
Kelly M. Chin
机构：
[1] University of Bologna and IRCCS-S.Orsola University Hospital,Alma Mater Studiorum
[2] Mater Misericordiae University Hospital,David Geffen School of Medicine
[3] UCLA,undefined
[4] Royal Free Hospital,undefined
[5] Hannover Medical School and German Centre for Lung Research (DZL/BREATH),undefined
[6] Medical University of Vienna,undefined
[7] University of Michigan,undefined
[8] Actelion Pharmaceuticals Ltd,undefined
[9] University of California,undefined
[10] San Diego,undefined
[11] Hôpital Bicêtre,undefined
[12] Cedars-Sinai Medical Center,undefined
[13] University of Texas Southwestern Medical Center,undefined
[14] Université Paris-Sud,undefined
[15] INSERM Unité 999,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Selexipag; Pulmonary arterial hypertension; PAH; GRIPHON; Open-label extension; Safety; Tolerability; Survival; Combination therapy; Long-term outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：796 / 810
页数：14
相关论文
共 50 条
  • [1] Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
    Galie, Nazzareno
    Gaine, Sean
    Channick, Richard
    Coghlan, J. Gerry
    Hoeper, Marius M.
    Lang, Irene M.
    McLaughlin, Vallerie V.
    Lassen, Cheryl
    Rubin, Lewis J.
    Hsu Schmitz, Shu-Fang
    Sitbon, Olivier
    Tapson, Victor F.
    Chin, Kelly M.
    ADVANCES IN THERAPY, 2022, 39 (01) : 796 - 810
  • [2] Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension
    Galie, N.
    Gaine, S.
    Channick, R.
    Ghofrani, H. A.
    Hoeper, M.
    Lang, I.
    McLaughlin, V.
    Preiss, R.
    Rubin, L.
    Shiraga, Y.
    Simonneau, G.
    Sitbon, O.
    Tapson, V.
    Chin, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 631 - 632
  • [3] LONG-TERM SURVIVAL AND SAFETY WITH SELEXIPAG IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE GRIPHON STUDY AND ITS OPEN-LABEL EXTENSION
    Coghlan, J. G.
    Galie, N.
    Gaine, S.
    Channick, R.
    Ghofrani, H-A
    Hoeper, M.
    Lang, I.
    McLaughlin, V.
    Preiss, R.
    Rubin, L.
    Shiraga, Y.
    Simonneau, G.
    Sitbon, O.
    Tapson, V.
    Chin, K.
    THORAX, 2018, 73 : A76 - A77
  • [4] Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
    Rogério Souza
    Marion Delcroix
    Nazzareno Galié
    Pavel Jansa
    Sanjay Mehta
    Tomás Pulido
    Lewis Rubin
    B. K. S. Sastry
    Gérald Simonneau
    Olivier Sitbon
    Adam Torbicki
    Neli Boyanova
    Liliya Chamitava
    Claudia Stein
    Richard N. Channick
    Advances in Therapy, 2022, 39 : 4374 - 4390
  • [5] Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
    Souza, Rogerio
    Delcroix, Marion
    Galie, Nazzareno
    Jansa, Pavel
    Mehta, Sanjay
    Pulido, Tomas
    Rubin, Lewis
    Sastry, B. K. S.
    Simonneau, Gerald
    Sitbon, Olivier
    Torbicki, Adam
    Boyanova, Neli
    Chamitava, Liliya
    Stein, Claudia
    Channick, Richard N.
    ADVANCES IN THERAPY, 2022, 39 (09) : 4374 - 4390
  • [6] Long-Term Survival And Safety With Macitentan In Patients With Pulmonary Arterial Hypertension: Results From The Seraphin Study And Its Open-Label Extension
    Souza, R.
    Pulido, T.
    Channick, R. N.
    Delcroix, M.
    Galie, N.
    Ghofrani, H.
    Jansa, P.
    Mehta, S.
    Mitchell, L.
    Papadakis, K.
    Richard, D.
    Rubin, L. J.
    Sastry, B.
    Sitbon, O.
    Torbicki, A.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
    Ivy, Dunbar
    Beghetti, Maurice
    Juaneda-Simian, Ernesto
    Ravindranath, Ramiya
    Lukas, Mary Ann
    Machlitt-Northen, Sandra
    Scott, Nicola
    Narita, Jun
    Berger, Rolf M. F.
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (05) : 2123 - 2130
  • [8] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
    Dunbar Ivy
    Maurice Beghetti
    Ernesto Juaneda-Simian
    Ramiya Ravindranath
    Mary Ann Lukas
    Sandra Machlitt-Northen
    Nicola Scott
    Jun Narita
    Rolf M. F. Berger
    European Journal of Pediatrics, 2024, 183 : 2141 - 2153
  • [9] FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion
    Berger, Rolf M. F.
    Haworth, Sheila G.
    Bonnet, Damien
    Dulac, Yves
    Fraisse, Alain
    Galie, Nazzareno
    Ivy, D. Dunbar
    Jais, Xavier
    Miera, Oliver
    Rosenzweig, Erika B.
    Efficace, Michela
    Kusic-Pajic, Andjela
    Beghetti, Maurice
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 52 - 58
  • [10] Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results
    Sitbon, Olivier
    Channick, Richard
    Chin, Kelly
    Frey, Aline
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Hoeper, Marius M.
    Lang, Irene
    Le Brun, Franck-Olivier
    McLaughlin, Vallerie
    Preiss, Ralph
    Rubin, Lewis J.
    Simonneau, Gerald
    Tapson, Victor
    Gaine, Sean
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345